Several studies have demonstrated that dysregulation of metabolic endotoxin/lipopolysaccharide levels in a rat model of DKD leads to activation of the NF-κB signaling pathway, increased levels of inflammatory cytokines in both the bloodstream and kidney, and activation of the innate immune system [75]. Here, NFKB1 is linked to diabetic kidney disease.